But because supplements are so unregulated, you can never really be completely sure whats in them
Our protocol goes far beyond the script, combining unlimited access to expert providers, personalized nutrition support, app-based tracking, and a connected patient community. In a retrospective analysis of 1,131 patients treated with the GLP-1 drug semaglutide, combined with individualized medical oversight, patients lost an average of 45.9 pounds (19.5% total body weight loss) at 52 weeks, with those extending to 68 weeks achieving an average total weight loss of 46.9 pounds (21.8%)
Mechanisms Under Investigation Current scientific literature describes Retatrutide as a peptide designed to activate GLP-1, GIP, and glucagon receptors
GLP-1S Peptide Research Overview GLP-1S is a high-purity, research grade glucagon like peptide 1 developed for laboratory investigation of metabolic regulation, incretin signaling, glucose homeostasis, and energy balance
J Int Soc Sports Nutr 10(1):6 Li N, Chen S, He Y, Chen Y, Duan X, He W et al (2025) Effects of oral supplementation of beta -hydroxy-beta -methylbutyrate on muscle mass and strength in individuals over the age of 50: a meta-analysis
Retatrutide, a GIP, GLP-1 and Glucagon Receptor Agonist, for People With Type 2 Diabetes: A Randomised, Double-Blind, Placebo and Active-Controlled, Parallel-Group, Phase 2 Trial